Hutchison China Meditech Ltd (LSE:HCM) - Share price - Overview

Stock Report

Hutchison China Meditech Ltd HCM

Last Price
GBX5,262.50

Day Change
100.00|1.94%

As of 17/11/2017
17:53:48 GMT | GBX
Minimum 15 Minutes Delay.

Last Close5,162.50p
Day Range5,200.00 - 5,310.00
Mkt Cap3.50Bil
52-Wk Range1,872.50 - 5,310.00
Yield %0.00
ISINKYG4672N1016
Volume97,005
P/E354.31
P/S19.63
P/CF-443.31

Share Price

Total Returns 17/11/2017

 Chg (%)  
More ...
Hutchison China Meditech Ltd16.75 
FTSE 100 TR GBP-1.44
 
Financials
201420152016
More ...
Income Statement
Turnover53.14116.64160.07
Operating Profit-11.11-6.40-34.59
Net Profit-12.96-7.95-38.29
Reported EPS-38.94-41.8914.82
Balance Sheet
Current Assets57.7260.73135.46
Non Current Assets77.7495.04141.67
Total Assets135.46155.78277.13
Current Liabilities48.3855.0076.98
Total Liabilities98.8986.38111.99
Total Equity36.5769.39165.14
Cash Flow
Operating Cash Flow5.09-6.14-7.09
Net Change in Cash-4.56-3.9336.50
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
29/08/2017PurchaseSimon To3,769.444,597173,281.00
28/08/2017PurchaseSimon To3,792.682,777105,323.00
21/08/2017PurchaseEdith Shih1,290.103003,870.00
21/08/2017PurchaseEdith Shih1,290.6247607.00

Company Profile

Hutchison China Meditech Ltd is a major drug manufacturing company. The company operates two platforms--an innovation platform and a commercial platform aimed at discovering and developing therapeutics in oncology and autoimmune diseases.

Sector

Drug Manufacturers - Major

Market Position

125 of 1833 Companies

Index

FTSE AIM 100 ,FTSE AIM All Share

Outlook

(31/07/2017) no outlook statement

Next Event 31/12/2017

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)0.0013.6316.14
Div Yld (E)0.004.134.26
PEG (E)0.001.241.34
ROCE-16.65180.3415.81
Op Mrgn-21.38-8.42-9.53
EPS Grwth0.0012.8214.73
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanSimon To
Chief Executive OfficerChristian Hogg
Chief Financial OfficerJohnny Fung
Company SecretaryEdith Shih
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.